Compare UNB & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNB | ORMP |
|---|---|---|
| Founded | 1891 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.6M | 104.6M |
| IPO Year | 1998 | N/A |
| Metric | UNB | ORMP |
|---|---|---|
| Price | $23.75 | $3.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.2K | ★ 272.5K |
| Earning Date | 01-14-2026 | 11-13-2025 |
| Dividend Yield | ★ 6.07% | N/A |
| EPS Growth | 27.30 | ★ 838.25 |
| EPS | ★ 2.47 | 1.03 |
| Revenue | ★ $52,533,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.61 | ★ $2.99 |
| Revenue Growth | ★ 13.25 | N/A |
| 52 Week Low | $20.65 | $1.82 |
| 52 Week High | $36.00 | $3.20 |
| Indicator | UNB | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 57.58 | 73.89 |
| Support Level | $22.96 | $2.66 |
| Resistance Level | $23.95 | $3.20 |
| Average True Range (ATR) | 0.68 | 0.16 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 66.82 | 79.71 |
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.